nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—epilepsy syndrome	0.191	1	CbGaD
Carfilzomib—ABCB1—Levetiracetam—epilepsy syndrome	0.0602	0.208	CbGbCtD
Carfilzomib—ABCB1—Clobazam—epilepsy syndrome	0.0417	0.144	CbGbCtD
Carfilzomib—ABCB1—Lamotrigine—epilepsy syndrome	0.0402	0.139	CbGbCtD
Carfilzomib—ABCB1—Carbamazepine—epilepsy syndrome	0.0346	0.12	CbGbCtD
Carfilzomib—ABCB1—Phenytoin—epilepsy syndrome	0.031	0.107	CbGbCtD
Carfilzomib—ABCB1—Phenobarbital—epilepsy syndrome	0.0276	0.0957	CbGbCtD
Carfilzomib—ABCB1—Midazolam—epilepsy syndrome	0.0272	0.0944	CbGbCtD
Carfilzomib—ABCB1—Diazepam—epilepsy syndrome	0.0262	0.0907	CbGbCtD
Carfilzomib—PSMB10—head—epilepsy syndrome	0.00339	0.0501	CbGeAlD
Carfilzomib—PSMB10—nervous system—epilepsy syndrome	0.00321	0.0475	CbGeAlD
Carfilzomib—PSMB5—telencephalon—epilepsy syndrome	0.00309	0.0458	CbGeAlD
Carfilzomib—PSMB10—central nervous system—epilepsy syndrome	0.00309	0.0458	CbGeAlD
Carfilzomib—PSMB10—cerebellum—epilepsy syndrome	0.00302	0.0447	CbGeAlD
Carfilzomib—PSMB2—forebrain—epilepsy syndrome	0.00287	0.0425	CbGeAlD
Carfilzomib—PSMB1—telencephalon—epilepsy syndrome	0.0027	0.0401	CbGeAlD
Carfilzomib—PSMB2—telencephalon—epilepsy syndrome	0.00264	0.0391	CbGeAlD
Carfilzomib—PSMB10—brain—epilepsy syndrome	0.00245	0.0363	CbGeAlD
Carfilzomib—PSMB5—medulla oblongata—epilepsy syndrome	0.00243	0.036	CbGeAlD
Carfilzomib—PSMB5—midbrain—epilepsy syndrome	0.00222	0.0329	CbGeAlD
Carfilzomib—PSMB5—spinal cord—epilepsy syndrome	0.00217	0.0321	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—epilepsy syndrome	0.00213	0.0315	CbGeAlD
Carfilzomib—PSMB2—medulla oblongata—epilepsy syndrome	0.00207	0.0307	CbGeAlD
Carfilzomib—PSMB1—midbrain—epilepsy syndrome	0.00194	0.0288	CbGeAlD
Carfilzomib—PSMB2—midbrain—epilepsy syndrome	0.0019	0.0281	CbGeAlD
Carfilzomib—PSMB1—spinal cord—epilepsy syndrome	0.0019	0.0281	CbGeAlD
Carfilzomib—PSMB2—spinal cord—epilepsy syndrome	0.00185	0.0274	CbGeAlD
Carfilzomib—PSMB5—cerebellum—epilepsy syndrome	0.00172	0.0255	CbGeAlD
Carfilzomib—PSMB1—head—epilepsy syndrome	0.00168	0.0249	CbGeAlD
Carfilzomib—PSMB2—head—epilepsy syndrome	0.00164	0.0243	CbGeAlD
Carfilzomib—PSMB1—nervous system—epilepsy syndrome	0.0016	0.0236	CbGeAlD
Carfilzomib—PSMB8—brain—epilepsy syndrome	0.00158	0.0234	CbGeAlD
Carfilzomib—Ritonavir—SLCO1A2—epilepsy syndrome	0.00157	0.225	CrCbGaD
Carfilzomib—PSMB2—nervous system—epilepsy syndrome	0.00156	0.0231	CbGeAlD
Carfilzomib—PSMB1—central nervous system—epilepsy syndrome	0.00154	0.0228	CbGeAlD
Carfilzomib—PSMB1—cerebellum—epilepsy syndrome	0.0015	0.0223	CbGeAlD
Carfilzomib—PSMB2—central nervous system—epilepsy syndrome	0.0015	0.0222	CbGeAlD
Carfilzomib—PSMB2—cerebellum—epilepsy syndrome	0.00147	0.0217	CbGeAlD
Carfilzomib—PSMB8—Pentobarbital—Amobarbital—epilepsy syndrome	0.00146	0.253	CbGdCrCtD
Carfilzomib—PSMB5—brain—epilepsy syndrome	0.0014	0.0207	CbGeAlD
Carfilzomib—Pentagastrin—BCHE—epilepsy syndrome	0.00139	0.199	CrCbGaD
Carfilzomib—PSMB8—Pentobarbital—Phenobarbital—epilepsy syndrome	0.00129	0.224	CbGdCrCtD
Carfilzomib—PSMB1—brain—epilepsy syndrome	0.00122	0.0181	CbGeAlD
Carfilzomib—PSMB2—brain—epilepsy syndrome	0.00119	0.0176	CbGeAlD
Carfilzomib—Ritonavir—ABCC2—epilepsy syndrome	0.000753	0.108	CrCbGaD
Carfilzomib—Ritonavir—ABCG2—epilepsy syndrome	0.000666	0.0953	CrCbGaD
Carfilzomib—PSMB8—Bortezomib—Lacosamide—epilepsy syndrome	0.00065	0.113	CbGdCrCtD
Carfilzomib—PSMB8—Alprazolam—Clonazepam—epilepsy syndrome	0.000637	0.11	CbGdCrCtD
Carfilzomib—Lopinavir—CYP2C19—epilepsy syndrome	0.000623	0.0891	CrCbGaD
Carfilzomib—PSMB8—Alprazolam—Midazolam—epilepsy syndrome	0.000608	0.105	CbGdCrCtD
Carfilzomib—PSMB8—Alprazolam—Clobazam—epilepsy syndrome	0.000583	0.101	CbGdCrCtD
Carfilzomib—PSMB8—Alprazolam—Diazepam—epilepsy syndrome	0.000542	0.0939	CbGdCrCtD
Carfilzomib—Ritonavir—CYP2C19—epilepsy syndrome	0.000524	0.0749	CrCbGaD
Carfilzomib—Lopinavir—CYP2D6—epilepsy syndrome	0.000462	0.0661	CrCbGaD
Carfilzomib—ABCB1—forebrain—epilepsy syndrome	0.000438	0.00649	CbGeAlD
Carfilzomib—ABCB1—telencephalon—epilepsy syndrome	0.000403	0.00597	CbGeAlD
Carfilzomib—Ritonavir—CYP2D6—epilepsy syndrome	0.000388	0.0556	CrCbGaD
Carfilzomib—Lopinavir—ABCB1—epilepsy syndrome	0.00033	0.0472	CrCbGaD
Carfilzomib—ABCB1—medulla oblongata—epilepsy syndrome	0.000317	0.00469	CbGeAlD
Carfilzomib—ABCB1—midbrain—epilepsy syndrome	0.00029	0.00429	CbGeAlD
Carfilzomib—ABCB1—spinal cord—epilepsy syndrome	0.000282	0.00418	CbGeAlD
Carfilzomib—Ritonavir—ABCB1—epilepsy syndrome	0.000277	0.0397	CrCbGaD
Carfilzomib—Fatigue—Felbamate—epilepsy syndrome	0.00026	0.00101	CcSEcCtD
Carfilzomib—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000259	0.00101	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000259	0.001	CcSEcCtD
Carfilzomib—Infection—Lamotrigine—epilepsy syndrome	0.000259	0.001	CcSEcCtD
Carfilzomib—Constipation—Felbamate—epilepsy syndrome	0.000258	0.000999	CcSEcCtD
Carfilzomib—Pain—Felbamate—epilepsy syndrome	0.000258	0.000999	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000257	0.000997	CcSEcCtD
Carfilzomib—Nausea—Lacosamide—epilepsy syndrome	0.000257	0.000997	CcSEcCtD
Carfilzomib—Insomnia—Clonazepam—epilepsy syndrome	0.000257	0.000997	CcSEcCtD
Carfilzomib—Anorexia—Carbamazepine—epilepsy syndrome	0.000257	0.000996	CcSEcCtD
Carfilzomib—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000256	0.000994	CcSEcCtD
Carfilzomib—Decreased appetite—Zonisamide—epilepsy syndrome	0.000256	0.000994	CcSEcCtD
Carfilzomib—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000256	0.000993	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000256	0.000992	CcSEcCtD
Carfilzomib—Insomnia—Phenytoin—epilepsy syndrome	0.000255	0.00099	CcSEcCtD
Carfilzomib—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000255	0.000989	CcSEcCtD
Carfilzomib—Fatigue—Zonisamide—epilepsy syndrome	0.000254	0.000986	CcSEcCtD
Carfilzomib—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000254	0.000985	CcSEcCtD
Carfilzomib—Dyspnoea—Clonazepam—epilepsy syndrome	0.000253	0.000982	CcSEcCtD
Carfilzomib—Constipation—Zonisamide—epilepsy syndrome	0.000252	0.000978	CcSEcCtD
Carfilzomib—Dyspnoea—Phenytoin—epilepsy syndrome	0.000252	0.000976	CcSEcCtD
Carfilzomib—ABCB1—head—epilepsy syndrome	0.000251	0.00372	CbGeAlD
Carfilzomib—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.00025	0.000971	CcSEcCtD
Carfilzomib—Body temperature increased—Vigabatrin—epilepsy syndrome	0.00025	0.000969	CcSEcCtD
Carfilzomib—Nausea—Clobazam—epilepsy syndrome	0.00025	0.000968	CcSEcCtD
Carfilzomib—Asthenia—Propofol—epilepsy syndrome	0.00025	0.000968	CcSEcCtD
Carfilzomib—Anorexia—Lamotrigine—epilepsy syndrome	0.000248	0.000962	CcSEcCtD
Carfilzomib—Dizziness—Acetazolamide—epilepsy syndrome	0.000248	0.00096	CcSEcCtD
Carfilzomib—Decreased appetite—Clonazepam—epilepsy syndrome	0.000247	0.000958	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000246	0.000952	CcSEcCtD
Carfilzomib—Decreased appetite—Phenytoin—epilepsy syndrome	0.000245	0.000951	CcSEcCtD
Carfilzomib—Back pain—Valproic Acid—epilepsy syndrome	0.000245	0.000951	CcSEcCtD
Carfilzomib—Fatigue—Clonazepam—epilepsy syndrome	0.000245	0.00095	CcSEcCtD
Carfilzomib—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000244	0.000948	CcSEcCtD
Carfilzomib—Asthenia—Midazolam—epilepsy syndrome	0.000244	0.000947	CcSEcCtD
Carfilzomib—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000244	0.000946	CcSEcCtD
Carfilzomib—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000244	0.000945	CcSEcCtD
Carfilzomib—Insomnia—Carbamazepine—epilepsy syndrome	0.000244	0.000945	CcSEcCtD
Carfilzomib—Fatigue—Phenytoin—epilepsy syndrome	0.000243	0.000944	CcSEcCtD
Carfilzomib—Pain—Clonazepam—epilepsy syndrome	0.000243	0.000942	CcSEcCtD
Carfilzomib—Constipation—Clonazepam—epilepsy syndrome	0.000243	0.000942	CcSEcCtD
Carfilzomib—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000242	0.000939	CcSEcCtD
Carfilzomib—Constipation—Phenytoin—epilepsy syndrome	0.000241	0.000936	CcSEcCtD
Carfilzomib—Asthenia—Levetiracetam—epilepsy syndrome	0.000241	0.000935	CcSEcCtD
Carfilzomib—Hypoaesthesia—Gabapentin—epilepsy syndrome	0.00024	0.000931	CcSEcCtD
Carfilzomib—Dyspnoea—Carbamazepine—epilepsy syndrome	0.00024	0.000931	CcSEcCtD
Carfilzomib—Pain—Oxcarbazepine—epilepsy syndrome	0.00024	0.000931	CcSEcCtD
Carfilzomib—Constipation—Oxcarbazepine—epilepsy syndrome	0.00024	0.000931	CcSEcCtD
Carfilzomib—Body temperature increased—Felbamate—epilepsy syndrome	0.000238	0.000923	CcSEcCtD
Carfilzomib—Vomiting—Acetazolamide—epilepsy syndrome	0.000238	0.000923	CcSEcCtD
Carfilzomib—Diarrhoea—Propofol—epilepsy syndrome	0.000238	0.000923	CcSEcCtD
Carfilzomib—ABCB1—nervous system—epilepsy syndrome	0.000238	0.00353	CbGeAlD
Carfilzomib—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000238	0.000922	CcSEcCtD
Carfilzomib—Neutropenia—Topiramate—epilepsy syndrome	0.000237	0.00092	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000237	0.00092	CcSEcCtD
Carfilzomib—Chills—Pregabalin—epilepsy syndrome	0.000236	0.000916	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000236	0.000915	CcSEcCtD
Carfilzomib—Insomnia—Lamotrigine—epilepsy syndrome	0.000236	0.000913	CcSEcCtD
Carfilzomib—Headache—Acetazolamide—epilepsy syndrome	0.000235	0.00091	CcSEcCtD
Carfilzomib—Anaemia—Valproic Acid—epilepsy syndrome	0.000234	0.000909	CcSEcCtD
Carfilzomib—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000234	0.000908	CcSEcCtD
Carfilzomib—Body temperature increased—Zonisamide—epilepsy syndrome	0.000233	0.000904	CcSEcCtD
Carfilzomib—Asthenia—Fosphenytoin—epilepsy syndrome	0.000233	0.000902	CcSEcCtD
Carfilzomib—Fatigue—Carbamazepine—epilepsy syndrome	0.000232	0.000901	CcSEcCtD
Carfilzomib—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000232	0.0009	CcSEcCtD
Carfilzomib—Constipation—Carbamazepine—epilepsy syndrome	0.00023	0.000893	CcSEcCtD
Carfilzomib—Pain—Carbamazepine—epilepsy syndrome	0.00023	0.000893	CcSEcCtD
Carfilzomib—Dizziness—Propofol—epilepsy syndrome	0.00023	0.000892	CcSEcCtD
Carfilzomib—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00023	0.000891	CcSEcCtD
Carfilzomib—ABCB1—central nervous system—epilepsy syndrome	0.000229	0.00339	CbGeAlD
Carfilzomib—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000229	0.000888	CcSEcCtD
Carfilzomib—Pneumonia—Topiramate—epilepsy syndrome	0.000228	0.000882	CcSEcCtD
Carfilzomib—Leukopenia—Valproic Acid—epilepsy syndrome	0.000227	0.00088	CcSEcCtD
Carfilzomib—Asthenia—Vigabatrin—epilepsy syndrome	0.000227	0.000879	CcSEcCtD
Carfilzomib—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000226	0.000878	CcSEcCtD
Carfilzomib—Dizziness—Midazolam—epilepsy syndrome	0.000225	0.000872	CcSEcCtD
Carfilzomib—Body temperature increased—Clonazepam—epilepsy syndrome	0.000225	0.000871	CcSEcCtD
Carfilzomib—Fatigue—Lamotrigine—epilepsy syndrome	0.000225	0.00087	CcSEcCtD
Carfilzomib—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000224	0.000869	CcSEcCtD
Carfilzomib—ABCB1—cerebellum—epilepsy syndrome	0.000224	0.00332	CbGeAlD
Carfilzomib—Asthenia—Diazepam—epilepsy syndrome	0.000223	0.000866	CcSEcCtD
Carfilzomib—Body temperature increased—Phenytoin—epilepsy syndrome	0.000223	0.000865	CcSEcCtD
Carfilzomib—Pain—Lamotrigine—epilepsy syndrome	0.000223	0.000863	CcSEcCtD
Carfilzomib—Constipation—Lamotrigine—epilepsy syndrome	0.000223	0.000863	CcSEcCtD
Carfilzomib—Renal failure—Topiramate—epilepsy syndrome	0.000223	0.000862	CcSEcCtD
Carfilzomib—Nausea—Acetazolamide—epilepsy syndrome	0.000223	0.000862	CcSEcCtD
Carfilzomib—Dizziness—Levetiracetam—epilepsy syndrome	0.000222	0.000862	CcSEcCtD
Carfilzomib—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000222	0.000861	CcSEcCtD
Carfilzomib—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000222	0.00086	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000222	0.00086	CcSEcCtD
Carfilzomib—Back pain—Pregabalin—epilepsy syndrome	0.000222	0.00086	CcSEcCtD
Carfilzomib—Cough—Valproic Acid—epilepsy syndrome	0.000221	0.000858	CcSEcCtD
Carfilzomib—Vomiting—Propofol—epilepsy syndrome	0.000221	0.000857	CcSEcCtD
Carfilzomib—Muscle spasms—Pregabalin—epilepsy syndrome	0.00022	0.000854	CcSEcCtD
Carfilzomib—Hypertension—Valproic Acid—epilepsy syndrome	0.000219	0.000849	CcSEcCtD
Carfilzomib—Headache—Propofol—epilepsy syndrome	0.000218	0.000845	CcSEcCtD
Carfilzomib—Chills—Gabapentin—epilepsy syndrome	0.000217	0.00084	CcSEcCtD
Carfilzomib—Vomiting—Midazolam—epilepsy syndrome	0.000216	0.000839	CcSEcCtD
Carfilzomib—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000216	0.000839	CcSEcCtD
Carfilzomib—Asthenia—Felbamate—epilepsy syndrome	0.000216	0.000838	CcSEcCtD
Carfilzomib—Arthralgia—Valproic Acid—epilepsy syndrome	0.000216	0.000837	CcSEcCtD
Carfilzomib—Dizziness—Fosphenytoin—epilepsy syndrome	0.000215	0.000832	CcSEcCtD
Carfilzomib—Vomiting—Levetiracetam—epilepsy syndrome	0.000214	0.000828	CcSEcCtD
Carfilzomib—Headache—Midazolam—epilepsy syndrome	0.000213	0.000827	CcSEcCtD
Carfilzomib—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000213	0.000826	CcSEcCtD
Carfilzomib—Diarrhoea—Diazepam—epilepsy syndrome	0.000213	0.000826	CcSEcCtD
Carfilzomib—Anaemia—Pregabalin—epilepsy syndrome	0.000212	0.000821	CcSEcCtD
Carfilzomib—Asthenia—Zonisamide—epilepsy syndrome	0.000212	0.00082	CcSEcCtD
Carfilzomib—Headache—Levetiracetam—epilepsy syndrome	0.000211	0.000816	CcSEcCtD
Carfilzomib—Dizziness—Vigabatrin—epilepsy syndrome	0.000209	0.000811	CcSEcCtD
Carfilzomib—Nausea—Propofol—epilepsy syndrome	0.000207	0.000801	CcSEcCtD
Carfilzomib—Vomiting—Fosphenytoin—epilepsy syndrome	0.000206	0.0008	CcSEcCtD
Carfilzomib—Diarrhoea—Felbamate—epilepsy syndrome	0.000206	0.000799	CcSEcCtD
Carfilzomib—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000206	0.000798	CcSEcCtD
Carfilzomib—Dizziness—Diazepam—epilepsy syndrome	0.000206	0.000798	CcSEcCtD
Carfilzomib—Infection—Valproic Acid—epilepsy syndrome	0.000206	0.000797	CcSEcCtD
Carfilzomib—Leukopenia—Pregabalin—epilepsy syndrome	0.000205	0.000796	CcSEcCtD
Carfilzomib—Asthenia—Clonazepam—epilepsy syndrome	0.000204	0.000791	CcSEcCtD
Carfilzomib—Back pain—Gabapentin—epilepsy syndrome	0.000203	0.000788	CcSEcCtD
Carfilzomib—Headache—Fosphenytoin—epilepsy syndrome	0.000203	0.000788	CcSEcCtD
Carfilzomib—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000203	0.000786	CcSEcCtD
Carfilzomib—Asthenia—Phenytoin—epilepsy syndrome	0.000203	0.000785	CcSEcCtD
Carfilzomib—Nausea—Midazolam—epilepsy syndrome	0.000202	0.000784	CcSEcCtD
Carfilzomib—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000202	0.000784	CcSEcCtD
Carfilzomib—Muscle spasms—Gabapentin—epilepsy syndrome	0.000202	0.000784	CcSEcCtD
Carfilzomib—Diarrhoea—Zonisamide—epilepsy syndrome	0.000202	0.000782	CcSEcCtD
Carfilzomib—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000202	0.000781	CcSEcCtD
Carfilzomib—Vomiting—Vigabatrin—epilepsy syndrome	0.000201	0.000779	CcSEcCtD
Carfilzomib—Oedema peripheral—Topiramate—epilepsy syndrome	0.0002	0.000776	CcSEcCtD
Carfilzomib—Cough—Pregabalin—epilepsy syndrome	0.0002	0.000776	CcSEcCtD
Carfilzomib—Nausea—Levetiracetam—epilepsy syndrome	0.0002	0.000774	CcSEcCtD
Carfilzomib—Dizziness—Felbamate—epilepsy syndrome	0.000199	0.000772	CcSEcCtD
Carfilzomib—Headache—Vigabatrin—epilepsy syndrome	0.000198	0.000768	CcSEcCtD
Carfilzomib—Hypertension—Pregabalin—epilepsy syndrome	0.000198	0.000767	CcSEcCtD
Carfilzomib—Vomiting—Diazepam—epilepsy syndrome	0.000198	0.000767	CcSEcCtD
Carfilzomib—Anorexia—Valproic Acid—epilepsy syndrome	0.000197	0.000765	CcSEcCtD
Carfilzomib—Arthralgia—Pregabalin—epilepsy syndrome	0.000195	0.000757	CcSEcCtD
Carfilzomib—Dizziness—Zonisamide—epilepsy syndrome	0.000195	0.000756	CcSEcCtD
Carfilzomib—Headache—Diazepam—epilepsy syndrome	0.000195	0.000756	CcSEcCtD
Carfilzomib—Diarrhoea—Clonazepam—epilepsy syndrome	0.000195	0.000754	CcSEcCtD
Carfilzomib—Anaemia—Gabapentin—epilepsy syndrome	0.000194	0.000753	CcSEcCtD
Carfilzomib—Asthenia—Carbamazepine—epilepsy syndrome	0.000193	0.00075	CcSEcCtD
Carfilzomib—Diarrhoea—Phenytoin—epilepsy syndrome	0.000193	0.000749	CcSEcCtD
Carfilzomib—Nausea—Fosphenytoin—epilepsy syndrome	0.000193	0.000747	CcSEcCtD
Carfilzomib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000192	0.000745	CcSEcCtD
Carfilzomib—Vomiting—Felbamate—epilepsy syndrome	0.000192	0.000743	CcSEcCtD
Carfilzomib—Headache—Felbamate—epilepsy syndrome	0.000189	0.000732	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000189	0.000731	CcSEcCtD
Carfilzomib—Cardiac disorder—Topiramate—epilepsy syndrome	0.000189	0.000731	CcSEcCtD
Carfilzomib—Leukopenia—Gabapentin—epilepsy syndrome	0.000188	0.000729	CcSEcCtD
Carfilzomib—Dizziness—Clonazepam—epilepsy syndrome	0.000188	0.000729	CcSEcCtD
Carfilzomib—Nausea—Vigabatrin—epilepsy syndrome	0.000188	0.000728	CcSEcCtD
Carfilzomib—Vomiting—Zonisamide—epilepsy syndrome	0.000188	0.000727	CcSEcCtD
Carfilzomib—Insomnia—Valproic Acid—epilepsy syndrome	0.000187	0.000726	CcSEcCtD
Carfilzomib—Asthenia—Lamotrigine—epilepsy syndrome	0.000187	0.000724	CcSEcCtD
Carfilzomib—Dizziness—Phenytoin—epilepsy syndrome	0.000187	0.000724	CcSEcCtD
Carfilzomib—Infection—Pregabalin—epilepsy syndrome	0.000186	0.000721	CcSEcCtD
Carfilzomib—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000186	0.00072	CcSEcCtD
Carfilzomib—Nausea—Diazepam—epilepsy syndrome	0.000185	0.000717	CcSEcCtD
Carfilzomib—Headache—Zonisamide—epilepsy syndrome	0.000185	0.000716	CcSEcCtD
Carfilzomib—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000185	0.000715	CcSEcCtD
Carfilzomib—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000184	0.000715	CcSEcCtD
Carfilzomib—Cough—Gabapentin—epilepsy syndrome	0.000183	0.000711	CcSEcCtD
Carfilzomib—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000183	0.00071	CcSEcCtD
Carfilzomib—Chills—Topiramate—epilepsy syndrome	0.000182	0.000707	CcSEcCtD
Carfilzomib—ABCB1—brain—epilepsy syndrome	0.000182	0.00269	CbGeAlD
Carfilzomib—Hypertension—Gabapentin—epilepsy syndrome	0.000182	0.000704	CcSEcCtD
Carfilzomib—Vomiting—Clonazepam—epilepsy syndrome	0.000181	0.000701	CcSEcCtD
Carfilzomib—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00018	0.000697	CcSEcCtD
Carfilzomib—Vomiting—Phenytoin—epilepsy syndrome	0.00018	0.000696	CcSEcCtD
Carfilzomib—Arthralgia—Gabapentin—epilepsy syndrome	0.000179	0.000694	CcSEcCtD
Carfilzomib—Nausea—Felbamate—epilepsy syndrome	0.000179	0.000694	CcSEcCtD
Carfilzomib—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000179	0.000692	CcSEcCtD
Carfilzomib—Fatigue—Valproic Acid—epilepsy syndrome	0.000178	0.000692	CcSEcCtD
Carfilzomib—Anorexia—Pregabalin—epilepsy syndrome	0.000178	0.000691	CcSEcCtD
Carfilzomib—Dizziness—Carbamazepine—epilepsy syndrome	0.000178	0.000691	CcSEcCtD
Carfilzomib—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000178	0.000691	CcSEcCtD
Carfilzomib—Headache—Clonazepam—epilepsy syndrome	0.000178	0.00069	CcSEcCtD
Carfilzomib—Constipation—Valproic Acid—epilepsy syndrome	0.000177	0.000686	CcSEcCtD
Carfilzomib—Pain—Valproic Acid—epilepsy syndrome	0.000177	0.000686	CcSEcCtD
Carfilzomib—Headache—Phenytoin—epilepsy syndrome	0.000177	0.000686	CcSEcCtD
Carfilzomib—Headache—Oxcarbazepine—epilepsy syndrome	0.000176	0.000682	CcSEcCtD
Carfilzomib—Nausea—Zonisamide—epilepsy syndrome	0.000175	0.000679	CcSEcCtD
Carfilzomib—Dizziness—Lamotrigine—epilepsy syndrome	0.000172	0.000668	CcSEcCtD
Carfilzomib—Vomiting—Carbamazepine—epilepsy syndrome	0.000171	0.000664	CcSEcCtD
Carfilzomib—Back pain—Topiramate—epilepsy syndrome	0.000171	0.000663	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.00017	0.000661	CcSEcCtD
Carfilzomib—Infection—Gabapentin—epilepsy syndrome	0.00017	0.000661	CcSEcCtD
Carfilzomib—Muscle spasms—Topiramate—epilepsy syndrome	0.00017	0.000659	CcSEcCtD
Carfilzomib—Insomnia—Pregabalin—epilepsy syndrome	0.000169	0.000656	CcSEcCtD
Carfilzomib—Nausea—Clonazepam—epilepsy syndrome	0.000169	0.000654	CcSEcCtD
Carfilzomib—Headache—Carbamazepine—epilepsy syndrome	0.000169	0.000654	CcSEcCtD
Carfilzomib—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000168	0.000651	CcSEcCtD
Carfilzomib—Nausea—Phenytoin—epilepsy syndrome	0.000168	0.00065	CcSEcCtD
Carfilzomib—Dyspnoea—Pregabalin—epilepsy syndrome	0.000167	0.000647	CcSEcCtD
Carfilzomib—Nausea—Oxcarbazepine—epilepsy syndrome	0.000167	0.000647	CcSEcCtD
Carfilzomib—Vomiting—Lamotrigine—epilepsy syndrome	0.000166	0.000642	CcSEcCtD
Carfilzomib—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000164	0.000634	CcSEcCtD
Carfilzomib—Anorexia—Gabapentin—epilepsy syndrome	0.000164	0.000634	CcSEcCtD
Carfilzomib—Anaemia—Topiramate—epilepsy syndrome	0.000163	0.000634	CcSEcCtD
Carfilzomib—Headache—Lamotrigine—epilepsy syndrome	0.000163	0.000633	CcSEcCtD
Carfilzomib—Decreased appetite—Pregabalin—epilepsy syndrome	0.000163	0.000631	CcSEcCtD
Carfilzomib—Fatigue—Pregabalin—epilepsy syndrome	0.000161	0.000625	CcSEcCtD
Carfilzomib—Nausea—Carbamazepine—epilepsy syndrome	0.00016	0.000621	CcSEcCtD
Carfilzomib—Constipation—Pregabalin—epilepsy syndrome	0.00016	0.00062	CcSEcCtD
Carfilzomib—Pain—Pregabalin—epilepsy syndrome	0.00016	0.00062	CcSEcCtD
Carfilzomib—Leukopenia—Topiramate—epilepsy syndrome	0.000158	0.000614	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000156	0.000606	CcSEcCtD
Carfilzomib—Insomnia—Gabapentin—epilepsy syndrome	0.000155	0.000602	CcSEcCtD
Carfilzomib—Nausea—Lamotrigine—epilepsy syndrome	0.000155	0.0006	CcSEcCtD
Carfilzomib—Cough—Topiramate—epilepsy syndrome	0.000154	0.000598	CcSEcCtD
Carfilzomib—Dyspnoea—Gabapentin—epilepsy syndrome	0.000153	0.000593	CcSEcCtD
Carfilzomib—Hypertension—Topiramate—epilepsy syndrome	0.000153	0.000592	CcSEcCtD
Carfilzomib—Arthralgia—Topiramate—epilepsy syndrome	0.000151	0.000584	CcSEcCtD
Carfilzomib—Decreased appetite—Gabapentin—epilepsy syndrome	0.000149	0.000578	CcSEcCtD
Carfilzomib—Asthenia—Valproic Acid—epilepsy syndrome	0.000149	0.000576	CcSEcCtD
Carfilzomib—Fatigue—Gabapentin—epilepsy syndrome	0.000148	0.000573	CcSEcCtD
Carfilzomib—Body temperature increased—Pregabalin—epilepsy syndrome	0.000148	0.000573	CcSEcCtD
Carfilzomib—Constipation—Gabapentin—epilepsy syndrome	0.000147	0.000569	CcSEcCtD
Carfilzomib—Pain—Gabapentin—epilepsy syndrome	0.000147	0.000569	CcSEcCtD
Carfilzomib—Infection—Topiramate—epilepsy syndrome	0.000143	0.000556	CcSEcCtD
Carfilzomib—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000142	0.000549	CcSEcCtD
Carfilzomib—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000141	0.000548	CcSEcCtD
Carfilzomib—Anorexia—Topiramate—epilepsy syndrome	0.000138	0.000533	CcSEcCtD
Carfilzomib—Dizziness—Valproic Acid—epilepsy syndrome	0.000137	0.000531	CcSEcCtD
Carfilzomib—Body temperature increased—Gabapentin—epilepsy syndrome	0.000136	0.000526	CcSEcCtD
Carfilzomib—Asthenia—Pregabalin—epilepsy syndrome	0.000134	0.00052	CcSEcCtD
Carfilzomib—Vomiting—Valproic Acid—epilepsy syndrome	0.000132	0.00051	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000132	0.00051	CcSEcCtD
Carfilzomib—Insomnia—Topiramate—epilepsy syndrome	0.000131	0.000506	CcSEcCtD
Carfilzomib—Headache—Valproic Acid—epilepsy syndrome	0.00013	0.000503	CcSEcCtD
Carfilzomib—Dyspnoea—Topiramate—epilepsy syndrome	0.000129	0.000499	CcSEcCtD
Carfilzomib—Diarrhoea—Pregabalin—epilepsy syndrome	0.000128	0.000496	CcSEcCtD
Carfilzomib—Decreased appetite—Topiramate—epilepsy syndrome	0.000126	0.000486	CcSEcCtD
Carfilzomib—Fatigue—Topiramate—epilepsy syndrome	0.000124	0.000482	CcSEcCtD
Carfilzomib—Dizziness—Pregabalin—epilepsy syndrome	0.000124	0.00048	CcSEcCtD
Carfilzomib—Constipation—Topiramate—epilepsy syndrome	0.000123	0.000479	CcSEcCtD
Carfilzomib—Pain—Topiramate—epilepsy syndrome	0.000123	0.000479	CcSEcCtD
Carfilzomib—Asthenia—Gabapentin—epilepsy syndrome	0.000123	0.000477	CcSEcCtD
Carfilzomib—Nausea—Valproic Acid—epilepsy syndrome	0.000123	0.000477	CcSEcCtD
Carfilzomib—Vomiting—Pregabalin—epilepsy syndrome	0.000119	0.000461	CcSEcCtD
Carfilzomib—Diarrhoea—Gabapentin—epilepsy syndrome	0.000117	0.000455	CcSEcCtD
Carfilzomib—Headache—Pregabalin—epilepsy syndrome	0.000117	0.000454	CcSEcCtD
Carfilzomib—Body temperature increased—Topiramate—epilepsy syndrome	0.000114	0.000442	CcSEcCtD
Carfilzomib—Dizziness—Gabapentin—epilepsy syndrome	0.000113	0.00044	CcSEcCtD
Carfilzomib—Nausea—Pregabalin—epilepsy syndrome	0.000111	0.000431	CcSEcCtD
Carfilzomib—Vomiting—Gabapentin—epilepsy syndrome	0.000109	0.000423	CcSEcCtD
Carfilzomib—Headache—Gabapentin—epilepsy syndrome	0.000108	0.000417	CcSEcCtD
Carfilzomib—Asthenia—Topiramate—epilepsy syndrome	0.000104	0.000401	CcSEcCtD
Carfilzomib—Nausea—Gabapentin—epilepsy syndrome	0.000102	0.000395	CcSEcCtD
Carfilzomib—Diarrhoea—Topiramate—epilepsy syndrome	9.88e-05	0.000383	CcSEcCtD
Carfilzomib—Dizziness—Topiramate—epilepsy syndrome	9.55e-05	0.00037	CcSEcCtD
Carfilzomib—Vomiting—Topiramate—epilepsy syndrome	9.18e-05	0.000356	CcSEcCtD
Carfilzomib—Headache—Topiramate—epilepsy syndrome	9.04e-05	0.000351	CcSEcCtD
Carfilzomib—Nausea—Topiramate—epilepsy syndrome	8.58e-05	0.000332	CcSEcCtD
Carfilzomib—PSMB2—Metabolism—APOE—epilepsy syndrome	1.48e-05	8.11e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOE—epilepsy syndrome	1.48e-05	8.11e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.47e-05	8.08e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FYN—epilepsy syndrome	1.47e-05	8.06e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FYN—epilepsy syndrome	1.47e-05	8.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FYN—epilepsy syndrome	1.47e-05	8.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.46e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—H2AFX—epilepsy syndrome	1.46e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—H2AFX—epilepsy syndrome	1.46e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MEF2C—epilepsy syndrome	1.46e-05	8.02e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MEF2C—epilepsy syndrome	1.46e-05	8.02e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.46e-05	8.02e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOE—epilepsy syndrome	1.46e-05	8e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF2—epilepsy syndrome	1.45e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF2—epilepsy syndrome	1.45e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF2—epilepsy syndrome	1.45e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FYN—epilepsy syndrome	1.45e-05	7.95e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.44e-05	7.93e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—H2AFX—epilepsy syndrome	1.44e-05	7.92e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MEF2C—epilepsy syndrome	1.44e-05	7.9e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—AKT1—epilepsy syndrome	1.43e-05	7.86e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF2—epilepsy syndrome	1.43e-05	7.86e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—AKT1—epilepsy syndrome	1.42e-05	7.82e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.41e-05	7.75e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.41e-05	7.75e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—YWHAZ—epilepsy syndrome	1.41e-05	7.75e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.41e-05	7.75e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.41e-05	7.75e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—POMC—epilepsy syndrome	1.4e-05	7.69e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—SRC—epilepsy syndrome	1.4e-05	7.67e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NGF—epilepsy syndrome	1.4e-05	7.66e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NGF—epilepsy syndrome	1.4e-05	7.66e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NGF—epilepsy syndrome	1.4e-05	7.66e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—POMC—epilepsy syndrome	1.39e-05	7.65e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—YWHAZ—epilepsy syndrome	1.39e-05	7.64e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—SRC—epilepsy syndrome	1.39e-05	7.63e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.38e-05	7.58e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BCL2—epilepsy syndrome	1.38e-05	7.57e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BCL2—epilepsy syndrome	1.38e-05	7.57e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BCL2—epilepsy syndrome	1.38e-05	7.57e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NGF—epilepsy syndrome	1.38e-05	7.55e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCL2—epilepsy syndrome	1.37e-05	7.52e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL2—epilepsy syndrome	1.36e-05	7.49e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BCL2—epilepsy syndrome	1.36e-05	7.46e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—epilepsy syndrome	1.36e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—epilepsy syndrome	1.36e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—epilepsy syndrome	1.36e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.35e-05	7.43e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—RELA—epilepsy syndrome	1.35e-05	7.4e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—RELA—epilepsy syndrome	1.35e-05	7.4e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—RELA—epilepsy syndrome	1.35e-05	7.4e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF2—epilepsy syndrome	1.34e-05	7.36e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF2—epilepsy syndrome	1.34e-05	7.36e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGF2—epilepsy syndrome	1.34e-05	7.36e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—epilepsy syndrome	1.34e-05	7.35e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—epilepsy syndrome	1.34e-05	7.33e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—epilepsy syndrome	1.33e-05	7.3e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.33e-05	7.29e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.33e-05	7.29e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR2A—epilepsy syndrome	1.33e-05	7.29e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—RELA—epilepsy syndrome	1.33e-05	7.29e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.33e-05	7.28e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MTOR—epilepsy syndrome	1.32e-05	7.25e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MTOR—epilepsy syndrome	1.32e-05	7.25e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MTOR—epilepsy syndrome	1.32e-05	7.25e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF2—epilepsy syndrome	1.32e-05	7.25e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR2A—epilepsy syndrome	1.31e-05	7.19e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MTOR—epilepsy syndrome	1.3e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.3e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.29e-05	7.11e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—SRC—epilepsy syndrome	1.29e-05	7.08e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—SRC—epilepsy syndrome	1.28e-05	7.05e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—POMC—epilepsy syndrome	1.27e-05	6.97e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—POMC—epilepsy syndrome	1.27e-05	6.97e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—POMC—epilepsy syndrome	1.27e-05	6.97e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TSC2—epilepsy syndrome	1.26e-05	6.93e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TSC2—epilepsy syndrome	1.26e-05	6.93e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TSC2—epilepsy syndrome	1.26e-05	6.93e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.26e-05	6.92e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AGT—epilepsy syndrome	1.26e-05	6.92e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AGT—epilepsy syndrome	1.26e-05	6.92e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AGT—epilepsy syndrome	1.26e-05	6.92e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—POMC—epilepsy syndrome	1.25e-05	6.87e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TSC2—epilepsy syndrome	1.24e-05	6.83e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AGT—epilepsy syndrome	1.24e-05	6.82e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF2—epilepsy syndrome	1.24e-05	6.8e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOE—epilepsy syndrome	1.23e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOE—epilepsy syndrome	1.23e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOE—epilepsy syndrome	1.23e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF2—epilepsy syndrome	1.23e-05	6.76e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MTOR—epilepsy syndrome	1.22e-05	6.7e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MTOR—epilepsy syndrome	1.22e-05	6.7e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MTOR—epilepsy syndrome	1.22e-05	6.7e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.22e-05	6.69e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—epilepsy syndrome	1.22e-05	6.69e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—epilepsy syndrome	1.22e-05	6.69e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—epilepsy syndrome	1.22e-05	6.69e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOE—epilepsy syndrome	1.22e-05	6.69e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KDR—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KDR—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KDR—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—epilepsy syndrome	1.21e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MTOR—epilepsy syndrome	1.2e-05	6.6e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—epilepsy syndrome	1.2e-05	6.59e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.2e-05	6.59e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KDR—epilepsy syndrome	1.19e-05	6.55e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—epilepsy syndrome	1.19e-05	6.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.18e-05	6.49e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—JUN—epilepsy syndrome	1.18e-05	6.48e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—JUN—epilepsy syndrome	1.18e-05	6.48e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—JUN—epilepsy syndrome	1.18e-05	6.48e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PRKCB—epilepsy syndrome	1.16e-05	6.4e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PRKCB—epilepsy syndrome	1.16e-05	6.4e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PRKCB—epilepsy syndrome	1.16e-05	6.4e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—JUN—epilepsy syndrome	1.16e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6ST—epilepsy syndrome	1.16e-05	6.37e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6ST—epilepsy syndrome	1.16e-05	6.37e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6ST—epilepsy syndrome	1.16e-05	6.37e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—epilepsy syndrome	1.16e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—epilepsy syndrome	1.16e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—epilepsy syndrome	1.16e-05	6.35e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RELA—epilepsy syndrome	1.15e-05	6.31e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-05	6.3e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RELA—epilepsy syndrome	1.14e-05	6.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6ST—epilepsy syndrome	1.14e-05	6.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—epilepsy syndrome	1.14e-05	6.26e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MTOR—epilepsy syndrome	1.13e-05	6.19e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MTOR—epilepsy syndrome	1.12e-05	6.16e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—AKT1—epilepsy syndrome	1.08e-05	5.96e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—AKT1—epilepsy syndrome	1.08e-05	5.96e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—AKT1—epilepsy syndrome	1.08e-05	5.96e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.08e-05	5.93e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.07e-05	5.87e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.07e-05	5.87e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—AKT1—epilepsy syndrome	1.07e-05	5.87e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—epilepsy syndrome	1.06e-05	5.83e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—epilepsy syndrome	1.06e-05	5.83e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—epilepsy syndrome	1.06e-05	5.83e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—SRC—epilepsy syndrome	1.06e-05	5.81e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—SRC—epilepsy syndrome	1.06e-05	5.81e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—SRC—epilepsy syndrome	1.06e-05	5.81e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—epilepsy syndrome	1.05e-05	5.74e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—SRC—epilepsy syndrome	1.04e-05	5.73e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL2—epilepsy syndrome	1.04e-05	5.7e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL2—epilepsy syndrome	1.04e-05	5.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL2—epilepsy syndrome	1.04e-05	5.7e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CASP3—epilepsy syndrome	1.04e-05	5.69e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CASP3—epilepsy syndrome	1.03e-05	5.66e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL2—epilepsy syndrome	1.02e-05	5.62e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—epilepsy syndrome	1.01e-05	5.56e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—epilepsy syndrome	1.01e-05	5.56e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—epilepsy syndrome	1.01e-05	5.56e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—JUN—epilepsy syndrome	1.01e-05	5.53e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—JUN—epilepsy syndrome	1e-05	5.5e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—epilepsy syndrome	9.98e-06	5.48e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—epilepsy syndrome	9.79e-06	5.38e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SRC—epilepsy syndrome	9.77e-06	5.37e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SRC—epilepsy syndrome	9.77e-06	5.37e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SRC—epilepsy syndrome	9.77e-06	5.37e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—epilepsy syndrome	9.75e-06	5.35e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SRC—epilepsy syndrome	9.63e-06	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF2—epilepsy syndrome	9.38e-06	5.15e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF2—epilepsy syndrome	9.38e-06	5.15e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF2—epilepsy syndrome	9.38e-06	5.15e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF2—epilepsy syndrome	9.25e-06	5.08e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SRC—epilepsy syndrome	9.03e-06	4.96e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SRC—epilepsy syndrome	8.99e-06	4.93e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—epilepsy syndrome	8.79e-06	4.83e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—epilepsy syndrome	8.75e-06	4.81e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.71e-06	4.79e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RELA—epilepsy syndrome	8.71e-06	4.78e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RELA—epilepsy syndrome	8.71e-06	4.78e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RELA—epilepsy syndrome	8.71e-06	4.78e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—AKT1—epilepsy syndrome	8.68e-06	4.77e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—AKT1—epilepsy syndrome	8.64e-06	4.74e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—AKT1—epilepsy syndrome	8.63e-06	4.74e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—AKT1—epilepsy syndrome	8.59e-06	4.72e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RELA—epilepsy syndrome	8.58e-06	4.71e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MTOR—epilepsy syndrome	8.54e-06	4.69e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MTOR—epilepsy syndrome	8.54e-06	4.69e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MTOR—epilepsy syndrome	8.54e-06	4.69e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.49e-06	4.66e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.44e-06	4.64e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MTOR—epilepsy syndrome	8.42e-06	4.62e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.04e-06	4.42e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—AKT1—epilepsy syndrome	8.01e-06	4.4e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—AKT1—epilepsy syndrome	7.97e-06	4.38e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CASP3—epilepsy syndrome	7.85e-06	4.31e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CASP3—epilepsy syndrome	7.85e-06	4.31e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CASP3—epilepsy syndrome	7.85e-06	4.31e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CASP3—epilepsy syndrome	7.74e-06	4.25e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—JUN—epilepsy syndrome	7.63e-06	4.19e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—JUN—epilepsy syndrome	7.63e-06	4.19e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—JUN—epilepsy syndrome	7.63e-06	4.19e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.62e-06	4.18e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—JUN—epilepsy syndrome	7.52e-06	4.13e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—epilepsy syndrome	7.42e-06	4.08e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—epilepsy syndrome	7.42e-06	4.08e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—epilepsy syndrome	7.42e-06	4.08e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—epilepsy syndrome	7.32e-06	4.02e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.26e-06	3.99e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.25e-06	3.98e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.22e-06	3.97e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.89e-06	3.78e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SRC—epilepsy syndrome	6.84e-06	3.76e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SRC—epilepsy syndrome	6.84e-06	3.76e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SRC—epilepsy syndrome	6.84e-06	3.76e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.81e-06	3.74e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TH—epilepsy syndrome	6.79e-06	3.73e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SRC—epilepsy syndrome	6.75e-06	3.7e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AKT1—epilepsy syndrome	6.71e-06	3.69e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AKT1—epilepsy syndrome	6.68e-06	3.67e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—epilepsy syndrome	6.66e-06	3.66e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—epilepsy syndrome	6.66e-06	3.66e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—epilepsy syndrome	6.66e-06	3.66e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—AKT1—epilepsy syndrome	6.58e-06	3.61e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—AKT1—epilepsy syndrome	6.58e-06	3.61e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—AKT1—epilepsy syndrome	6.58e-06	3.61e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—epilepsy syndrome	6.57e-06	3.61e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—AKT1—epilepsy syndrome	6.54e-06	3.59e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—AKT1—epilepsy syndrome	6.54e-06	3.59e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—AKT1—epilepsy syndrome	6.54e-06	3.59e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—AKT1—epilepsy syndrome	6.48e-06	3.56e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—AKT1—epilepsy syndrome	6.45e-06	3.54e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—AKT1—epilepsy syndrome	6.07e-06	3.33e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—AKT1—epilepsy syndrome	6.07e-06	3.33e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—AKT1—epilepsy syndrome	6.07e-06	3.33e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—AKT1—epilepsy syndrome	5.99e-06	3.29e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.67e-06	3.11e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AKT1—epilepsy syndrome	5.61e-06	3.08e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—epilepsy syndrome	5.59e-06	3.07e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AKT1—epilepsy syndrome	5.58e-06	3.07e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AKT1—epilepsy syndrome	5.09e-06	2.79e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AKT1—epilepsy syndrome	5.09e-06	2.79e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AKT1—epilepsy syndrome	5.09e-06	2.79e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX1—epilepsy syndrome	5.06e-06	2.78e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AKT1—epilepsy syndrome	5.01e-06	2.75e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AGT—epilepsy syndrome	4.43e-06	2.44e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—epilepsy syndrome	4.34e-06	2.39e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AKT1—epilepsy syndrome	4.25e-06	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AKT1—epilepsy syndrome	4.25e-06	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AKT1—epilepsy syndrome	4.25e-06	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AKT1—epilepsy syndrome	4.19e-06	2.3e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—epilepsy syndrome	3.73e-06	2.05e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—epilepsy syndrome	3.4e-06	1.87e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.98e-06	1.63e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.5e-06	8.22e-06	CbGpPWpGaD
